255 related articles for article (PubMed ID: 35898322)
1. Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity.
Carvalho DZ; St Louis EK; Przybelski SA; Morgenthaler TI; Machulda MM; Boeve BF; Petersen RC; Jack CR; Graff-Radford J; Vemuri P; Mielke MM
Front Aging Neurosci; 2022; 14():930315. PubMed ID: 35898322
[TBL] [Abstract][Full Text] [Related]
2. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults.
Sprecher KE; Koscik RL; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Sager MA; Asthana S; Johnson SC; Benca RM; Bendlin BB
Neurology; 2017 Aug; 89(5):445-453. PubMed ID: 28679595
[TBL] [Abstract][Full Text] [Related]
3. Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.
Shir D; Mielke MM; Hofrenning EI; Lesnick TG; Knopman DS; Petersen RC; Jack CR; Algeciras-Schimnich A; Vemuri P; Graff-Radford J
J Alzheimers Dis; 2023; 92(3):887-898. PubMed ID: 36806507
[TBL] [Abstract][Full Text] [Related]
4. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
6. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.
Bolsewig K; van Unnik AAJM; Blujdea ER; Gonzalez MC; Ashton NJ; Aarsland D; Zetterberg H; Padovani A; Bonanni L; Mollenhauer B; Schade S; Vandenberghe R; Poesen K; Kramberger MG; Paquet C; Bousiges O; Cretin B; Willemse EAJ; Teunissen CE; Lemstra AW;
Neurology; 2024 Jun; 102(12):e209418. PubMed ID: 38830138
[TBL] [Abstract][Full Text] [Related]
7. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
[TBL] [Abstract][Full Text] [Related]
8. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
9. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia.
Carvalho DZ; St Louis EK; Knopman DS; Boeve BF; Lowe VJ; Roberts RO; Mielke MM; Przybelski SA; Machulda MM; Petersen RC; Jack CR; Vemuri P
JAMA Neurol; 2018 Jun; 75(6):672-680. PubMed ID: 29532057
[TBL] [Abstract][Full Text] [Related]
10. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
11. Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.
Sun Q; Ni J; Wei M; Long S; Li T; Fan D; Lu T; Shi J; Tian J
Front Aging Neurosci; 2022; 14():963845. PubMed ID: 36062146
[TBL] [Abstract][Full Text] [Related]
12. Sex and Education Modify the Association Between Subjective Cognitive Decline and Amyloid Pathology.
Bolton CJ; Khan OA; Liu D; Wilhoite S; Dumitrescu L; Peterson A; Blennow K; Zetterberg H; Hohman TJ; Jefferson AL; Gifford KA
medRxiv; 2023 Nov; ():. PubMed ID: 37961115
[TBL] [Abstract][Full Text] [Related]
13. Combined Effects of Synaptic and Axonal Integrity on Longitudinal Gray Matter Atrophy in Cognitively Unimpaired Adults.
Saloner R; Fonseca C; Paolillo EW; Asken BM; Djukic NA; Lee S; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Kramer JH; Casaletto KB
Neurology; 2022 Nov; 99(20):e2285-e2293. PubMed ID: 36041868
[TBL] [Abstract][Full Text] [Related]
14. Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.
Rådestig MA; Skoog J; Zetterberg H; Skillbäck T; Zettergren A; Sterner TR; Fässberg MM; Sacuiu S; Waern M; Wetterberg H; Blennow K; Skoog I; Kern S
J Alzheimers Dis; 2023; 91(1):291-303. PubMed ID: 36617786
[TBL] [Abstract][Full Text] [Related]
15. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
[TBL] [Abstract][Full Text] [Related]
16. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.
Kern S; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Waern M; Hagen CE; van Harten AC; Knopman DS; Jack CR; Petersen RC; Mielke MM
JAMA Neurol; 2019 Feb; 76(2):187-193. PubMed ID: 30419087
[TBL] [Abstract][Full Text] [Related]
17. Insomnia Symptoms and Biomarkers of Alzheimer's Disease in the Community.
Nicolazzo J; Cavuoto M; Rowsthorn E; Cribb L; Bransby L; Gibson M; Wall P; Velakoulis D; Eratne D; Buckley R; Yassi N; Yiallourou S; Brodtmann A; Hamilton GS; Naughton MT; Lim YY; Pase MP
J Alzheimers Dis; 2023; 91(4):1423-1434. PubMed ID: 36641673
[TBL] [Abstract][Full Text] [Related]
18. Associations of sleep duration and daytime sleepiness with plasma amyloid beta and cognitive performance in cognitively unimpaired, middle-aged and older African Americans.
Cook JD; Malik A; Plante DT; Norton D; Langhough Koscik R; Du L; Bendlin BB; Kirmess KM; Holubasch MS; Meyer MR; Venkatesh V; West T; Verghese PB; Yarasheski KE; Thomas KV; Carlsson CM; Asthana S; Johnson SC; Gleason CE; Zuelsdorff M
Sleep; 2024 Jan; 47(1):. PubMed ID: 38011629
[TBL] [Abstract][Full Text] [Related]
19. Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort.
Planche V; Bouteloup V; Pellegrin I; Mangin JF; Dubois B; Ousset PJ; Pasquier F; Blanc F; Paquet C; Hanon O; Bennys K; Ceccaldi M; Annweiler C; Krolak-Salmon P; Godefroy O; Wallon D; Sauvee M; Boutoleau-Bretonnière C; Bourdel-Marchasson I; Jalenques I; Chene G; Dufouil C;
Neurology; 2023 Jan; 100(5):e473-e484. PubMed ID: 36261295
[TBL] [Abstract][Full Text] [Related]
20. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.
Guo T; Landau SM; Jagust WJ;
Alzheimers Res Ther; 2021 Oct; 13(1):174. PubMed ID: 34654465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
